US FDA considers publicising data on pending applications
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has announced a second meeting of its transparency task force that was set up earlier this year1,2. The move is in line with President Barack Obama’s commitment to achieve “an unprecedented level of openness in Government”3.
You may also be interested in...
Pharma Guidelines, ending 1 July 2011
Recently updated and newly issued documents
EuropaBio appoints new chairman
EuropaBio, the European biotech industry association, has appointed Stephan Tanda as its new association chair. Mr Tanda, a member of the managing board of life sciences and materials sciences firm DSM, succeeds GlaxoSmithKline's Andrea Rappagliosi, who will remain a member of the EuropaBio board.
Medtech Guidelines, ending 24 June 2011
Recently updated and newly issued documents